Markets In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Accuray (ARAY – Research Report), with a price target of $9.00. The company’s shares closed last Tuesday at $5.32, close to its 52-week high of $6.02. According to TipRanks.com, Thibault is a 5-star analyst with an average return of 74.2% and a 64.9% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Irhythm Technologies, and Edwards Lifesciences. Accuray has an analyst consensus of Moderate Buy, with a price target consensus of $8.00. The company has a one-year high of $6.02 and a one-year low of $1.75. Currently, Accuray has an average volume of 790.2K.